Nanoviricides Inc is a biotechnology company specializing in the development of antiviral therapeutics designed to combat a wide range of viral infections
The company focuses on utilizing nanotechnology to create a new class of drugs that can target viruses effectively by mimicking the host cells that viruses attack. Their innovative approach involves engineering nanoparticles that can specifically bind to viral particles, thereby neutralizing them and preventing the spread of infection. Through this cutting-edge research and development, Nanoviricides aims to address unmet medical needs in the field of infectious diseases, helping to safeguard public health against various viral threats.
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco
